157 related articles for article (PubMed ID: 23931030)
1. Toward a new concept of "natural balance" in oral estroprogestin contraception.
Chabbert-Buffet N; Gerris J; Jamin C; Lello S; Lete I; Lobo P; Nappi RE; Pintiaux A
Gynecol Endocrinol; 2013 Oct; 29(10):891-6. PubMed ID: 23931030
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic risks of oral contraceptives.
Rott H
Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of hormonal contraceptives-related venous thromboembolism.
Hugon-Rodin J; Gompel A; Plu-Bureau G
Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
[TBL] [Abstract][Full Text] [Related]
4. [Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].
Cremer P; Vekemans M
Rev Med Brux; 1987 Nov; 8(9):440-6. PubMed ID: 3423522
[No Abstract] [Full Text] [Related]
5. Hormonal contraceptives: pharmacology tailored to women's health.
De Leo V; Musacchio MC; Cappelli V; Piomboni P; Morgante G
Hum Reprod Update; 2016 Sep; 22(5):634-46. PubMed ID: 27307386
[TBL] [Abstract][Full Text] [Related]
6. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
7. Combined hormonal contraception and venous thromboembolism.
Martínez F; Avecilla A
Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
[TBL] [Abstract][Full Text] [Related]
8. The combined oral contraceptive pill -- recent developments, risks and benefits.
Dragoman MV
Best Pract Res Clin Obstet Gynaecol; 2014 Aug; 28(6):825-34. PubMed ID: 25028259
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
10. Combined hormonal contraception and the risk of venous thromboembolism: a guideline.
;
Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.
Dragoman MV; Tepper NK; Fu R; Curtis KM; Chou R; Gaffield ME
Int J Gynaecol Obstet; 2018 Jun; 141(3):287-294. PubMed ID: 29388678
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in hormonal contraception.
Erkkola R
Curr Opin Obstet Gynecol; 2007 Dec; 19(6):547-53. PubMed ID: 18007132
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
14. Hormonal contraception and thrombosis.
Sitruk-Ware R
Fertil Steril; 2016 Nov; 106(6):1289-1294. PubMed ID: 27678035
[TBL] [Abstract][Full Text] [Related]
15. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive tolerance: does the type of pill matter?
Moreau C; Trussell J; Gilbert F; Bajos N; Bouyer J
Obstet Gynecol; 2007 Jun; 109(6):1277-85. PubMed ID: 17540798
[TBL] [Abstract][Full Text] [Related]
17. [Oral contraception: failures and risks].
Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
[TBL] [Abstract][Full Text] [Related]
18. [Peroral hormonal contraception and risk of venous thromboembolism].
Ludka O; Spinar J; Musil V; Pozdísek Z
Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
[TBL] [Abstract][Full Text] [Related]
19. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
Shulman LP
Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of a low-dose contraceptive--Femodene].
Rachev E; Damianov L; Dukovski A; Katsarova M
Akush Ginekol (Sofiia); 1995; 34(3):71-3. PubMed ID: 8787249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
